Abstract
The development of dysfunctional or exhausted T cells is characteristic of immune responses to chronic viral infections and cancer. Exhausted T cells are defined by reduced effector function, sustained upregulation of multiple inhibitory receptors, an altered transcriptional program and perturbations of normal memory development and homeostasis. This review focuses on (a) illustrating milestone discoveries that led to our present understanding of T cell exhaustion, (b) summarizing recent developments in the field, and (c) identifying new challenges for translational research. Exhausted T cells are now recognized as key therapeutic targets in human infections and cancer. Much of our knowledge of the clinically relevant process of exhaustion derives from studies in the mouse model of Lymphocytic choriomeningitis virus (LCMV) infection. Studies using this model have formed the foundation for our understanding of human T cell memory and exhaustion. We will use this example to discuss recent advances in our understanding of T cell exhaustion and illustrate the value of integrated mouse and human studies and will emphasize the benefits of bi-directional mouse-to-human and human-to-mouse research approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed, R., Salmi, A., Butler, L. D., Chiller, J. M., & Oldstone, M. B. (1984). Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. The Journal of Experimental Medicine, 160(2), 521–540.
Alter, G., Hatzakis, G., Tsoukas, C. M., Pelley, K., Rouleau, D., LeBlanc, R., et al. (2003). Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. Journal of Immunology, 171(1), 477–488.
Amanna, I. J., Slifka, M. K., & Crotty, S. (2006). Immunity and immunological memory following smallpox vaccination. Immunological Reviews, 211, 320–337.
Angelosanto, J. M., Blackburn, S. D., Crawford, A., & Wherry, E. J. (2012). Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection. Journal of Virology, 86(15), 8161–8170.
Baitsch, L., Baumgaertner, P., Devevre, E., Raghav, S. K., Legat, A., Barba, L., et al. (2011). Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients. The Journal of Clinical Investigation, 121(6), 2350–2360.
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., et al. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 439(7077), 682–687.
Blackburn, S. D., Shin, H., Freeman, G. J., & Wherry, E. J. (2008). Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proceedings of the National Academy of Sciences of the United States of America, 105(39), 15016–15021.
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., et al. (2009). Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunology, 10(1), 29–37.
Blackburn, S. D., Crawford, A., Shin, H., Polley, A., Freeman, G. J., & Wherry, E. J. (2010). Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: Implications for CD8 T-cell exhaustion. Journal of Virology, 84(4), 2078–2089.
Brahmer, J. R., Tykodi, S. S., Chow, L. Q., Hwu, W. J., Topalian, S. L., Hwu, P., et al. (2012). Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. The New England Journal of Medicine, 366(26), 2455–2465.
Buchholz, V. R., Flossdorf, M., Hensel, I., Kretschmer, L., Weissbrich, B., Graf, P., et al. (2013). Disparate individual fates compose robust CD8+ T cell immunity. Science, 340(6132), 630–635.
Buggert, M., Tauriainen, J., Yamamoto, T., Frederiksen, J., Ivarsson, M. A., Michaelsson, J., et al. (2014). T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathogens, 10(7), e1004251.
Butz, E. A., & Bevan, M. J. (1998). Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity, 8(2), 167–175.
Casazza, J. P., Betts, M. R., Picker, L. J., & Koup, R. A. (2001). Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. Journal of Virology, 75(14), 6508–6516.
Crawford, A., Angelosanto, J. M., Kao, C., Doering, T. A., Odorizzi, P. M., Barnett, B. E., et al. (2014). Molecular and transcriptional basis of CD4(+) T cell dysfunction during chronic infection. Immunity, 40(2), 289–302.
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., et al. (2006). PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature, 443(7109), 350–354.
Dillon, S. R., Jameson, S. C., & Fink, P. J. (1994). V beta 5+ T cell receptors skew toward OVA + H-2Kb recognition. Journal of Immunology, 152(4), 1790–1801.
Doering, T. A., Crawford, A., Angelosanto, J. M., Paley, M. A., Ziegler, C. G., & Wherry, E. J. (2012). Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity, 37(6), 1130–1144.
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., et al. (1998). Changes in thymic function with age and during the treatment of HIV infection. Nature, 396(6712), 690–695.
Enouz, S., Carrie, L., Merkler, D., Bevan, M. J., & Zehn, D. (2012). Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. The Journal of Experimental Medicine, 209(10), 1769–1779.
Frebel, H., Nindl, V., Schuepbach, R. A., Braunschweiler, T., Richter, K., Vogel, J., et al. (2012). Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. The Journal of Experimental Medicine, 209(13), 2485–2499.
Fuller, M. J., & Zajac, A. J. (2003). Ablation of CD8 and CD4 T cell responses by high viral loads. Journal of Immunology, 170(1), 477–486.
Gallimore, A., Glithero, A., Godkin, A., Tissot, A. C., Pluckthun, A., Elliott, T., et al. (1998). Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. The Journal of Experimental Medicine, 187(9), 1383–1393.
Gerlach, C., Rohr, J. C., Perie, L., van Rooij N., van Heijst J. W., Velds, A., et al. (2013). Heterogeneous differentiation patterns of individual CD8+ T cells. Science, 340(6132), 635–639.
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., et al. (2013). Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. The New England Journal of Medicine, 369(2), 134–144.
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., et al. (2003). Duration of antiviral immunity after smallpox vaccination. Nature Medicine, 9(9), 1131–1137.
Harari, A., Dutoit, V., Cellerai, C., Bart, P. A., Du Pasquier R. A., & Pantaleo, G. (2006). Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunological Reviews, 211, 236–254.
Hertoghs, K. M., Moerland, P. D., van Stijn A., Remmerswaal, E. B., Yong, S. L., van de Berg P. J., et al. (2010). Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. The Journal of Clinical Investigation, 120(11), 4077–4090.
Jameson, S. C., & Masopust, D. (2009). Diversity in T cell memory: An embarrassment of riches. Immunity, 31(6), 859–871.
Jamieson, B. D., Yang, O. O., Hultin, L., Hausner, M. A., Hultin, P., Matud, J., et al. (2003). Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. Journal of Immunology, 171(10), 5372–5379.
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., et al. (1999). Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. The Journal of Experimental Medicine, 189(6), 991–998.
Kaech, S. M., & Cui, W. (2012). Transcriptional control of effector and memory CD8+ T cell differentiation. Nature Reviews Immunology, 12(11), 749–761.
Kao, C., Oestreich, K. J., Paley, M. A., Crawford, A., Angelosanto, J. M., Ali, M. A., et al. (2011). Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nature Immunology, 12(7), 663–671.
Kasprowicz, V., Schulze Zur Wiesch, J., Kuntzen, T., Nolan, B. E., Longworth, S., Berical, A., et al. (2008). High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. Journal of Virology, 82(6), 3154–3160.
Kelly, J. M., Sterry, S. J., Cose, S., Turner, S. J., Fecondo, J., Rodda, S., et al. (1993). Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant. European Journal of Immunology, 23(12), 3318–3326.
Kemball, C. C., Lee, E. D., Vezys, V., Pearson, T. C., Larsen, C. P., & Lukacher, A. E. (2005). Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection. Journal of Immunology, 174(12), 7950–7960.
Kim, P. S., & Ahmed, R. (2010). Features of responding T cells in cancer and chronic infection. Current Opinion in Immunology, 22(2), 223–230.
Klenerman, P., & Hill, A. (2005). T cells and viral persistence: Lessons from diverse infections. Nature Immunology, 6(9), 873–879.
Lau, L. L., Jamieson, B. D., Somasundaram, T., & Ahmed, R. (1994). Cytotoxic T-cell memory without antigen. Nature, 369(6482), 648–652.
Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., et al. (2004). HIV evolution: CTL escape mutation and reversion after transmission. Nature Medicine, 10(3), 282–289.
Lichterfeld, M., Yu, X. G., Mui, S. K., Williams, K. L., Trocha, A., Brockman, M. A., et al. (2007). Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. Journal of Virology, 81(8), 4199–4214.
Makedonas, G., & Betts, M. R. (2006). Polyfunctional analysis of human T cell responses: Importance in vaccine immunogenicity and natural infection. Springer Seminars in Immunopathology, 28(3), 209–219.
Masopust, D., Vezys, V., Wherry, E. J., Barber, D. L., & Ahmed, R. (2006). Cutting edge: Gut microenvironment promotes differentiation of a unique memory CD8 T cell population. Journal of Immunology, 176(4), 2079–2083.
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994). CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. Journal of Virology, 68(12), 8056–8063.
Miller, N. E., Bonczyk, J. R., Nakayama, Y., & Suresh, M. (2005). Role of thymic output in regulating CD8 T-cell homeostasis during acute and chronic viral infection. Journal of Virology, 79(15), 9419–9429.
Miller, J. D., van der Most R. G., Akondy, R. S., Glidewell, J. T., Albott, S., Masopust, D., et al. (2008). Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity, 28(5), 710–722.
Moskophidis, D., Lechner, F., Pircher, H., & Zinkernagel, R. M. (1993). Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature, 362(6422), 758–761.
Mueller, S. N., Gebhardt, T., Carbone, F. R., & Heath, W. R. (2013). Memory T cell subsets, migration patterns, and tissue residence. Annual Review of Immunology, 31, 137–161.
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., et al. (1998). Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity, 8(2), 177–187.
Odorizzi, P. M., Pauken, K. E., Paley, M. A., Sharpe, A., & Wherry, E. J. (2015). Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. J Exp Med.
Oldstone, M. B. (2002). Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Current Topics in Microbiology and Immunology, 263, 83–117.
Ortiz, G. M., Wellons, M., Brancato, J., Vo, H. T., Zinn, R. L., Clarkson, D. E., et al. (2001). Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proceedings of the National Academy of Sciences of the United States of America, 98(23), 13288–13293.
Paley, M. A., Kroy, D. C., Odorizzi, P. M., Johnnidis, J. B., Dolfi, D. V., Barnett, B. E., et al. (2012). Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science, 338(6111), 1220–1225.
Pauken, K. E., & Wherry, E. J. (2015). Overcoming T cell exhaustion in infection and cancer. Trends Immunol, 36, 265–276.
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., et al. (2006). PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. The Journal of Experimental Medicine, 203(10), 2281–2292.
Petrovic, D., Dempsey, E., Doherty, D. G., Kelleher, D., & Long, A. (2012). Hepatitis C virus-T-cell responses and viral escape mutations. European Journal of Immunology, 42(1), 17–26.
Quigley, M., Pereyra, F., Nilsson, B., Porichis, F., Fonseca, C., Eichbaum, Q., et al. (2010). Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nature Medicine, 16(10), 1147–1151.
Shin, H., Blackburn, S. D., Blattman, J. N., & Wherry, E. J. (2007). Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. The Journal of Experimental Medicine, 204(4), 941–949.
Schinazi, R., Halfon, P., Marcellin, P., & Asselah, T. (2014). HCV direct-acting antiviral agents: The best interferon-free combinations. Liver International: Official Journal of the International Association for the Study of the Liver, 34(Suppl 1), 69–78.
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., et al. (1999). Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science, 283(5403), 857–860.
Speiser, D. E., Utzschneider, D. T., Oberle, S. G., Munz, C., Romero, P., & Zehn, D. (2014). T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol, 14, 768–774.
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., et al. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. The New England Journal of Medicine, 366(26), 2443–2454.
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., et al. (2006). Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nature Medicine, 12(10), 1198–1202.
Utzschneider, D. T., Legat, A., Fuertes Marraco, S. A., Carrie, L., Luescher, I., Speiser, D. E., et al. (2013). T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nature Immunology, 14(6), 603–610.
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., et al. (2009). Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature, 458(7235), 206–210.
Vezys, V., Masopust, D., Kemball, C. C., Barber, D. L., O'Mara, L. A., Larsen, C. P., et al. (2006). Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. The Journal of Experimental Medicine, 203(10), 2263–2269.
Vigano, S., Utzschneider, D. T., Perreau, M., Pantaleo, G., Zehn, D., & Harari, A. (2012). Functional avidity: A measure to predict the efficacy of effector T cells? Clinical & Developmental Immunology, 2012, 153863.
Virgin, H. W., Wherry, E. J., & Ahmed, R. (2009). Redefining chronic viral infection. Cell, 138(1), 30–50.
Wherry, E. J. (2011). T cell exhaustion. Nature Immunology, 12(6), 492–499.
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most R., & Ahmed, R. (2003). Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. Journal of Virology, 77(8), 4911–4927.
Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N., & Ahmed, R. (2004). Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proceedings of the National Academy of Sciences of the United States of America, 101(45), 16004–16009.
Wherry, E. J., Ha, S. J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., et al. (2007). Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity, 27(4), 670–684.
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., et al. (2013). Nivolumab plus ipilimumab in advanced melanoma. The New England Journal of Medicine, 369(2), 122–133.
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D., et al. (1998). Viral immune evasion due to persistence of activated T cells without effector function. The Journal of Experimental Medicine, 188(12), 2205–2213.
Zehn, D., & Bevan, M. J. (2006). T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity, 25(2), 261–270.
Zehn, D., Lee, S. Y., & Bevan, M. J. (2009). Complete but curtailed T-cell response to very low-affinity antigen. Nature, 458(7235), 211–214.
Zhang, N., & Bevan, M. J. (2011). CD8(+) T cells: Foot soldiers of the immune system. Immunity, 35(2), 161–168.
Zinkernagel, R. M., & Doherty, P. C. (1974). Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature, 248(5450), 701–702.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Zehn, D., Wherry, E. (2015). Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model. In: Schoenberger, S., Katsikis, P., Pulendran, B. (eds) Crossroads Between Innate and Adaptive Immunity V. Advances in Experimental Medicine and Biology, vol 850. Springer, Cham. https://doi.org/10.1007/978-3-319-15774-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-15774-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15773-3
Online ISBN: 978-3-319-15774-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)